Making medicines more accessible right here in America

Our American pride, people and operations

Amneal was founded in 2002 by brothers Chirag and Chintu Patel who immigrated to America in pursuit of the American Dream. The brothers had a vision that medicines should not be a privilege, they should be accessible to all. So Chirag and Chintu set out to build an American company with a human purpose, a sharp focus on affordability and an unbreakable spirit.

This is our story of American ingenuity, value and impact.

Succeeding in the “land of opportunity”

160+ MILLION prescriptions filled per year for U.S. patients¹ | #1 U.S.-BASED COMPANY by total scripts in U.S. generics market² | $18.25 BILLION in estimated annual savings delivered to patients³

Our family makes medicines for your family

Across our broad Generic, Specialty, Biosimilar, and Injectable portfolios, we advance innovations that improve access to the medicines you need. Today ~160 of our FDA-approved medicines are made in the U.S.

OUR MADE-IN-AMERICA MEDICINES INCLUDE: Nasal Sprays, Oral liquids, Topicals, Transdermal, Ophthalmic, Innovative drug/device combinations, Antibiotics, Antivirals

We continue to invest in advanced pharmaceutical manufacturing in the United States, reflecting our commitment to producing essential medicines in America. We believe America must build a more resilient U.S. pharmaceutical supply chain to address national security and other global supply chain threats. Increasing sustained domestic capacity is critical to this mission, and we are eager to lead the charge.

Recent innovations for patients

CREXONT® (Opens in a new tab) (carbidopa and levodopa)
BREKIYA® (Opens in a new tab) (dihydroergotamine mesylate) autoinjector

Naloxone (Opens in a new tab) HCL Nasal Spray
Exenatide injection (Opens in a new tab) – a generic equivalent for Byetta® GLP-1

ALYMSYS® (Opens in a new tab) (bevacizumab-maly)
FYLNETRA® (Opens in a new tab) (pegfilgrastim-pbbk)
RELEUKO® (Opens in a new tab) (filgrastim-ayow)

BORUZU® (Opens in a new tab) (bortezomib injection)
PEMRYDI® (Opens in a new tab) (pemetrexed injection)
FOCINVEZ^TM (Opens in a new tab)(fosaprepitant injection)

Amneal has three reportable business segments: 1) Affordable Medicines (includes retail generics, injectables, biosimilars & international revenue), 2) Specialty and 3) AvKARE (includes distribution, government label and institutional revenue).

Learn how we support underserved patients across the U.S. through product donations

Other product donation partners

Providing thousands of high-quality jobs across U.S. operations

Amneal is headquartered in Bridgewater, NJ and has one of the largest U.S.-based manufacturing footprints in the industry. We also employ robust Specialty and Institutional commercial teams located across the U.S. See our career opportunities.

Piscataway NJ

380K Sq. Ft. / 4 Facilities

Oral Solids, Topicals, Transdermals, High Potency and Hormonal Products

Map

Helping the U.S. Government meet its public health mission

We contribute to emergency preparedness, health equity and local care initiatives. We also distribute medicines to the Federal Government through our Tennessee-based AvKARE independent subsidiary.

Learn how we collaborated with the U.S. Government on Pyridostigmine Bromide Extended Release to protect our troops from life-threatening risks on the battlefield.
Learn how we partner with the State of California to increase access to over-the-counter Naloxone HCL Nasal Spray (Opens in a new tab)

Source: IQVIA, Nation Prescription Audit, December 2024, Note: Total Scripts filled in 2024
Source: IQVIA, National Prescription Audit, March 2025, Amneal is headquartered in Bridgewater, NJ
Calculated by taking the total 2023 national savings estimated by the Association for Accessible Medicines and determining Amneal’s market share by volume, data of which was derived from IQVIA